You are here

Article info

Article menu
Immunotherapy biomarkers
Original research
Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy

Authors

  • Lin Shi Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, ChinaDepartment of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Jinying Lu Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, ChinaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Da Zhong Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Meijuan Song Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Jian Liu Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, ChinaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Wenhua You Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, ChinaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Wen-Hui Li Department of Hepatobiliary Surgery, The Yancheng School of Clinical Medicine of Nanjing Medical University, The Third People’s Hospital of Yancheng, Yancheng, China PubMed articlesGoogle scholar articles
  • Lin Lin Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Dongyan Shi Department of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Yun Chen Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, ChinaDepartment of Immunology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Gusu School, Nanjing Medical University, Nanjing, ChinaJiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yun Chen; chenyun{at}njmu.edu.cn; Dr Dongyan Shi; shidongyan{at}njmu.edu.cn; Dr Lin Lin; lin9100{at}aliyun.com; Dr Wen-Hui Li; 15189200969{at}163.com
View Full Text

Citation

Shi L, Lu J, Zhong D, et al
Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy
Journal for ImmunoTherapy of Cancer 2023;11:e005902. doi: 10.1136/jitc-2022-005902

Publication history

  • Accepted January 2, 2023
  • First published January 19, 2023.
Online issue publication 
December 07, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.